• レポートコード:TPM-2JN064 • 出版社/出版日:Transparency Market Research / 2019年11月28日 • レポート形態:英文、PDF、230ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは静脈瘤治療の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、治療タイプ別分析、製品別分析、疾患別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・静脈瘤治療の世界市場:治療タイプ別 ・静脈瘤治療の世界市場:製品別 ・静脈瘤治療の世界市場:疾患別 ・静脈瘤治療の世界市場:エンドユーザー別 ・静脈瘤治療の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ) ・静脈瘤治療の北米市場分析・予測 ・静脈瘤治療の欧州市場分析・予測 ・静脈瘤治療のアジア太平洋市場分析・予測 ・静脈瘤治療の中南米市場分析・予測 ・静脈瘤治療の中東・アフリカ市場分析・予測 ・競争状況 |
The varicose vein treatment market is anticipated to grow with the introduction of endovenous cyanoacrylate glue. For instance, a leading medical technology company – Medtronic – announced the launch of the VenaSeal closure system in India, which uses endovenous cyanoacrylate glue to seal off varicose veins. The procedure involving endovenous cyanoacrylate glue is increasingly gaining popularity as a minimally-invasive treatment option for patients in the varicose vein treatment space.
On the other hand, FDA-approved polidocanol injectable foam is being used by healthcare providers in the varicose vein treatment market space to diagnose the greater saphenous varicose vein condition in patients. As such, healthcare industries in the varicose vein treatment market are targeting treatment options for greater saphenous varicose veins, since the disease accounts for the highest revenue amongst all diseases in this landscape. Revenue of the greater saphenous varicose veins disease segment is predicted for exponential growth, with an estimated value of ~US$ 1 billion by the end of 2024. Healthcare providers are recommending polidocanol injectable foam for various varicose vein treatments, since it is a nonsurgical procedure.
The ClariVein® device is an important addition to the list of minimally-invasive treatment options in the varicose vein treatment ecosystem. This specialty infusion catheter is found to improve patient quality of life, owing to minimum recovery and maximum results. Thus, manufacturers should develop improved versions similar to ClariVein® to stay relevant in the varicose vein treatment market. This device adds convenience for patients since it is fully-disposable and can be easily used in an office setting.
Another device that is providing relief for challenging varicose vein health conditions is Sonovein®. In April 2019, Theraclion – a provider of HIFU (high-intensity focused ultrasound) technology devices, revealed that the company obtained the CE mark for the Sonovein® device, suitable for ultrasound therapy of the varicose veins. Thus, manufacturers in the varicose vein treatment landscape should innovate devices built with high-intensity ultrasound beams to contribute to more minimally-invasive treatment options.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Varicose Vein Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Rise in prevalence of varicose vein
4.3.1.2. Increase in awareness about varicose vein
4.3.1.3. Favorable reimbursement
4.3.1.4. Development of new treatments
4.3.2. Restraints
4.3.2.1. Complications associated with varicose vein treatment
4.3.2.2. High cost and low diagnosis rate
4.3.3. Opportunities
4.4. Global Varicose Vein Treatment Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Technological Advancements
5.2. Epidemiology of Varicose Veins Globally with Key Countries
5.3. Overview of Treatment and Management of Varicose Vein
5.4. Key Industry Events (product launch, approval, key merger & acquisition, etc.)
6. Global Varicose Vein Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2027
6.3.1. Endovenous Ablation
6.3.2. Sclerotherapy / Adhesion Injection
6.3.3. Ligation/Stripping
6.3.4. Supportive Treatments
6.4. Global Varicose Vein Treatment Market Attractiveness, by Treatment Type
7. Global Varicose Vein Treatment Market Analysis and Forecast, by Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Product, 2017–2027
7.3.1. Ablation Devices
7.3.1.1. Radio Frequency Ablation/Thermal Ablation
7.3.1.2. Laser Ablation Devices
7.3.1.3. Ultrasound Ablation Devices
7.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
7.3.3. Compression Devices / Garments
7.3.4. Others
7.4. Global Varicose Vein Treatment Market Attractiveness, by Product
8. Global Varicose Vein Treatment Market Analysis and Forecast, by Disease
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Disease, 2017–2027
8.3.1. Greater Saphenous Varicose Veins
8.3.2. Small Saphenous Varicose Vein
8.3.3. Others
8.4. Market Attractiveness, by Disease
9. Global Varicose Vein Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Global Varicose Vein Treatment Market Attractiveness, by End-user
10. Global Varicose Vein Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Varicose Vein Treatment Market Attractiveness, by Country/Region
11. North America Varicose Vein Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Varicose Vein Treatment Market Value Forecast, by Treatment Type, 2017–2027
11.2.1. Endovenous Ablation
11.2.2. Sclerotherapy / Adhesion Injection
11.2.3. Ligation/Stripping
11.2.4. Supportive Treatments
11.3. North America Varicose Vein Treatment Market Value Forecast, by Product, 2017–2027
11.3.1. Ablation Devices
11.3.1.1. Radio Frequency Ablation/Thermal Ablation
11.3.1.2. Laser Ablation Devices
11.3.1.3. Ultrasound Ablation Devices
11.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
11.3.3. Compression Devices / Garments
11.3.4. Others
11.4. North America Varicose Vein Treatment Market Value Forecast, by Disease , 2017–2027
11.4.1. Greater Saphenous Varicose Veins
11.4.2. Small Saphenous Varicose Vein
11.4.3. Others
11.5. North America Varicose Vein Treatment Market Value Forecast, by End-user, 2017–2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.6. North America Varicose Vein Treatment Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Varicose Vein Treatment Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Product
11.7.3. By Disease
11.7.4. By End-user
11.7.5. By Country
12. Europe Varicose Vein Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Varicose Vein Treatment Market Value Forecast, by Treatment Type, 2017–2027
12.2.1. Endovenous Ablation
12.2.2. Sclerotherapy / Adhesion Injection
12.2.3. Ligation/Stripping
12.2.4. Supportive Treatments
12.3. Europe Varicose Vein Treatment Market Value Forecast, by Product, 2017–2027
12.3.1. Ablation Devices
12.3.1.1. Radio Frequency Ablation/Thermal Ablation
12.3.1.2. Laser Ablation Devices
12.3.1.3. Ultrasound Ablation Devices
12.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
12.3.3. Compression Devices / Garments
12.3.4. Others
12.4. Europe Varicose Vein Treatment Market Value Forecast, by Disease, 2017–2027
12.4.1. Greater Saphenous Varicose Veins
12.4.2. Small Saphenous Varicose Vein
12.4.3. Others
12.5. Europe Varicose Vein Treatment Market Value Forecast, by End-user, 2017–2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.6. Europe Varicose Vein Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Varicose Vein Treatment Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Product
12.7.3. By Disease
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Varicose Vein Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Varicose Vein Treatment Market Value Forecast, by Treatment Type, 2017–2027
13.2.1. Endovenous Ablation
13.2.2. Sclerotherapy / Adhesion Injection
13.2.3. Ligation/Stripping
13.2.4. Supportive Treatments
13.3. Asia Pacific Varicose Vein Treatment Market Value Forecast, by Product, 2017–2027
13.3.1. Ablation Devices
13.3.1.1. Radio Frequency Ablation/Thermal Ablation
13.3.1.2. Laser Ablation Devices
13.3.1.3. Ultrasound Ablation Devices
13.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
13.3.3. Compression Devices / Garments
13.3.4. Others
13.4. Asia Pacific Varicose Vein Treatment Market Value Forecast, by Disease , 2017–2027
13.4.1. Greater Saphenous Varicose Veins
13.4.2. Small Saphenous Varicose Vein
13.4.3. Others
13.5. Asia Pacific Varicose Vein Treatment Market Value Forecast, by End-user, 2017–2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.6. Asia Pacific Varicose Vein Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Varicose Vein Treatment Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Product
13.7.3. By Disease
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Varicose Vein Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Varicose Vein Treatment Market Value Forecast, by Treatment Type, 2017–2027
14.2.1. Endovenous Ablation
14.2.2. Sclerotherapy / Adhesion Injection
14.2.3. Ligation/Stripping
14.2.4. Supportive Treatments
14.3. Latin America Varicose Vein Treatment Market Value Forecast, by Product, 2017–2027
14.3.1. Ablation Devices
14.3.1.1. Radio Frequency Ablation/Thermal Ablation
14.3.1.2. Laser Ablation Devices
14.3.1.3. Ultrasound Ablation Devices
14.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
14.3.3. Compression Devices / Garments
14.3.4. Others
14.4. Latin America Varicose Vein Treatment Market Value Forecast, by Disease, 2017–2027
14.4.1. Greater Saphenous Varicose Veins
14.4.2. Small Saphenous Varicose Vein
14.4.3. Others
14.5. Latin America Varicose Vein Treatment Market Value Forecast, by End-user, 2017–2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.6. Latin America Varicose Vein Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Varicose Vein Treatment Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Product
14.7.3. By Disease
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Varicose Vein Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Varicose Vein Treatment Market Value Forecast, by Treatment Type, 2017–2027
15.2.1. Endovenous Ablation
15.2.2. Sclerotherapy / Adhesion Injection
15.2.3. Ligation/Stripping
15.2.4. Supportive Treatments
15.3. Middle East & Africa Varicose Vein Treatment Market Value Forecast, by Product, 2017–2027
15.3.1. Ablation Devices
15.3.1.1. Radio Frequency Ablation/Thermal Ablation
15.3.1.2. Laser Ablation Devices
15.3.1.3. Ultrasound Ablation Devices
15.3.2. Catheters / Kits for Sclerotherapy & Adhesion Injection
15.3.3. Compression Devices / Garments
15.3.4. Others
15.4. Middle East & Africa Varicose Vein Treatment Market Value Forecast, by Disease, 2017–2027
15.4.1. Greater Saphenous Varicose Veins
15.4.2. Small Saphenous Varicose Vein
15.4.3. Others
15.5. Middle East & Africa Varicose Vein Treatment Market Value Forecast, by End-user, 2017–2027
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.6. Middle East & Africa Varicose Vein Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Varicose Vein Treatment Market Attractiveness Analysis
15.7.1. By Treatment Type
15.7.2. By Product
15.7.3. By Disease
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis/Ranking, by Company, 2018
16.3. Company Profiles
16.3.1. Medtronic
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. AngioDynamics
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. BTG International Ltd.
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. VVT Med
16.3.4.1. Company Overview
16.3.4.2. SWOT Analysis
16.3.5. F Care System
16.3.5.1. Company Overview
16.3.5.2. Growth Strategies
16.3.5.3. SWOT Analysis
16.3.6. WON TECH Co., Ltd.
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. DJO, LLC
16.3.7.1. Company Overview
16.3.7.2. Growth Strategies
16.3.7.3. SWOT Analysis
16.3.8. Miravas
16.3.8.1. Company Overview
16.3.8.2. Growth Strategies
16.3.8.3. SWOT Analysis
16.3.9. Mylan N.V.
16.3.9.1. Company Overview
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
16.3.10. Teleflex Incorporated
16.3.10.1. Company Overview
16.3.10.2. Company Financials
16.3.10.3. Growth Strategies
16.3.10.4. SWOT Analysis
16.3.11. BSN medical
16.3.11.1. Company Overview
16.3.11.2. Company Financials
16.3.11.3. Growth Strategies
16.3.11.4. SWOT Analysis
16.3.12. SIGVARIS
16.3.12.1. Company Overview
16.3.12.2. Growth Strategies
16.3.12.3. SWOT Analysis
List of TablesTable 01: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 02: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 03: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 04: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 05: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 08: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 09: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 10: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 11: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 12: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 13: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 14: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 16: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 17: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 18: Europe Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 20: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 21: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 22: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 23: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 24: Asia Pacific Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Latin America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 26: Latin America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 27: Latin America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 28: Latin America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 29: Latin America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 30: North America Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 31: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2017–2027
Table 32: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 33: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2027
Table 34: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Disease, 2017–2027
Table 35: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 36: Middle East & Africa Varicose Vein Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027